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Pathophysiological concentrations of ADMA alter human coronary 
artery endothelial cell gene expression: an insight into the 
pathophysiological significance of raised plasma ADMA levels. 
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Introduction: Asymmetric dimethylarginine (ADMA) is a naturally occurring 
inhibitor of nitric oxide synthases. ADMA accumulates in a wide range of 
diseases associated with endothelial dysfunction and enhanced 
atherosclerosis. Clinical studies implicate plasma ADMA as a major novel 
cardiovascular risk factor, but the mechanisms by which low concentrations of 
ADMA produce adverse effects on the cardiovascular system are unclear. 
 
Methods & Results: Human coronary artery endothelial cells were treated 
with pathophysiological concentrations of ADMA and the effects on gene 
expression were assessed using U133A GeneChips (Affymetrix). More than 
50 genes were significantly altered in endothelial cells after treatment with 
pathophysiological concentrations of ADMA (2 µM). Changes in several genes 
(including bone 
morphogenetic 2 inducible kinase (BMP2K), Smad5, BMP receptor 1A 
(BMPR1A) and protein arginine methyltransferase 3 (PRMT3)) were 
confirmed by northern blotting, Q-PCR and in some instances western blotting 
analysis to detect changes in protein expression. To determine whether these 
changes 
also occurred in vivo, tissue from gene deletion mice with raised ADMA levels 
was examined. Changes in BMP2K and PRMT3 were confirmed at mRNA in 
vivo. 
Conclusions: We detected specific patterns of changes that identify 
pathways involved in processes relevant to cardiovascular risk and pulmonary 
hypertension. Pathophysiological concentrations of ADMA are therefore 
sufficient to elicit significant changes in coronary artery endothelial cell gene 
expression. Changes in BMP signalling, and in enzymes involved in arginine 
methylation may be particularly relevant to understanding the 
pathophysiological 
significance of raised ADMA levels. This study identifies the mechanisms by 
which increased ADMA may contribute to common cardiovascular diseases 
and thereby indicates possible targets for therapies. 
 
